Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care
Neeraj Jain, Director of Growth Operations – Asia, Middle East & Europe (AMEE) at PATH, reposted from Maharashtra Arogya IEC Bureau on LinkedIn:
”Maharashtra continues to be at the forefront of strengthening the response to hemoglobinopathies.
This expert consultation, led by the Public Health Department, Maharashtra, marks an important step towards building a more coordinated, equitable, and sustainable approach to addressing hemoglobinopathies and hemophilia.
PATH remains committed to working alongside governments and partners to strengthen the prevention, diagnosis, and management of hashtag#hemoglobinopathies through integrated, people-centred approaches.
Grateful to BMS Foundation and Catharine Grimes, MBA, for their continued support in advancing integrated approaches to hemoglobinopathies, with a focus on thalassemia, in Maharashtra.”
Quoting Maharashtra Arogya IEC Bureau‘s post:
”Maharashtra has taken a significant step towards strengthening the prevention, diagnosis, treatment, and care of hemoglobinopathies and hemophilia through a comprehensive and integrated approach.
A lively and thought-provoking exchange of ideas marked the Maharashtra Integrated Haemoglobinopathies and Hemophilia Elimination Initiative (MHEI2026), held in Mumbai on 18 June 2026.
Convened by the Public Health Department, Government of Maharashtra, in collaboration with National Health Mission Maharashtra and PATH, the expert consultation brought together policymakers, clinicians, researchers, technical experts, and implementation partners to deliberate on a roadmap for the prevention, control, and comprehensive management of Sickle Cell Disease, Thalassemia, and Hemophilia in Maharashtra, while exploring a key question – How can Maharashtra build an integrated, equitable, and sustainable state-wide programme for the prevention, diagnosis, treatment, and long-term management of hemoglobinopathies and hemophilia?
The consultation focused on strengthening the entire continuum of care—from screening, diagnosis, prevention, counselling, and comprehensive treatment to patient support systems, day-care services, human resources, financing, surveillance, and community engagement.
The recommendations emerging from this consultation will help shape Maharashtra’s roadmap towards a more coordinated, equitable, and sustainable response to hemoglobinopathies and hemophilia, ultimately improving the quality of life and health outcomes of affected individuals and families across the state.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering